In addition, OLFML2B has been proven to be upregulated, presented a diagnostic and prognostic value (Liu et al., 2019), and correlated with the TME in GC and HCC (Ren et al., 2020) (Liu et al., 2020). This evidence concerns the gene OLFML2B and hepatocellular carcinoma.